Investor Relations

Press Releases

19 Jan 23

Prenetics Announces Dr. Bayju Thakar as Chief Executive Officer of Prenetics EMEA

LONDON and HONG KONG, Jan. 19, 2023 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE) a leader in genomic and diagnostic testing, today announced an executive leadership change to ensure the company realizes the full potential of its broad genetics and digital testing platform and as a

10 Jan 23

Prenetics Owned ACT Genomics Receives FDA Clearance for ACTOnco, the First Asia-Based Company to Receive Clearance for a Comprehensive Genomic Profiling Test for All Solid Tumors

Prenetics has completed the majority stake acquisition of ACT Genomics to spearhead its entry into to the US$80+ billion global precision oncology market FDA market authorization advances personalized cancer care in Asia Clearance sets the stage for continued R&D investment into early detection /

16 Dec 22

Prenetics Acquires ACT Genomics, Creating a Leader in Comprehensive Cancer Genetics and Precision Oncology

Acquisition to bring germline and somatic testing, cell-free DNA-based (liquid biopsy), and tissue-genomic profiling onto a single platform Cancer genomics testing is now standard practice for cancer care and has shown to be highly successful such as Foundation One (acquired by Roche), Grail

01 Dec 22

CirclePaw: The New DNA Test for Dogs that Provides 200+ Insights into Your Pet’s Breed & Health Risks

[Hong Kong, 30 November 2022] All any pet parent wants is to give their dog the best life possible – but when our dogs can’t tell us exactly what they’re feeling or what they need, how can we know that we’re doing the right things for our pets? This is the question that industry-leading

View All News

Key Financial
Guidance 2022

Stock Information

Press Releases

Recent Events

Featured Reports

INVESTOR RELATIONS

Key Financial Guidance 2022

Stock Information

Press Releases

Recent Events

Featured Reports

Key Financial
Guidance 2022